{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:52:46Z","timestamp":1778507566279,"version":"3.51.4"},"publisher-location":"Cham","reference-count":183,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031803956","type":"print"},{"value":"9783031803963","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-80396-3_4","type":"book-chapter","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:59:32Z","timestamp":1742356772000},"page":"93-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma"],"prefix":"10.1007","author":[{"given":"Friedhelm","family":"Raue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Frank-Raue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"9","key":"4_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamasurg.2017.1665","volume":"152","author":"MA Adam","year":"2017","unstructured":"Adam MA, Thomas S, Roman SA, Hyslop T, Sosa JA (2017) Rethinking the current American joint committee on cancer TNM staging system for medullary thyroid cancer. JAMA Surg 152(9):869\u2013876. https:\/\/doi.org\/10.1001\/jamasurg.2017.1665","journal-title":"JAMA Surg"},{"issue":"2","key":"4_CR2","doi-asserted-by":"publisher","first-page":"E364","DOI":"10.1210\/jc.2012-2703","volume":"98","author":"N Agrawal","year":"2013","unstructured":"Agrawal N, Jiao Y, Sausen M, Leary R, Bettegowda C, Roberts NJ et al (2013) Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin Endocrinol Metab 98(2):E364\u2013E369. https:\/\/doi.org\/10.1210\/jc.2012-2703","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4_CR3","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2010-2359","volume":"96","author":"SR Ahmed","year":"2011","unstructured":"Ahmed SR, Ball DW (2011) Clinical review: incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 96(5):1237\u20131245. https:\/\/doi.org\/10.1210\/jc.2010-2359","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000497201","volume":"8","author":"R Alencar","year":"2019","unstructured":"Alencar R, Kendler DB, Andrade F, Nava C, Bulzico D, Cordeiro de Noronha Pessoa C et al (2019) CA19-9 as a predictor of worse clinical outcome in medullary thyroid carcinoma. Eur Thyroid J 8(4):186\u2013191. https:\/\/doi.org\/10.1159\/000497201","journal-title":"Eur Thyroid J"},{"issue":"3","key":"4_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1210\/jc.2008-1862","volume":"94","author":"A Algeciras-Schimnich","year":"2009","unstructured":"Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK (2009) Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 94(3):861\u2013868. https:\/\/doi.org\/10.1210\/jc.2008-1862","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-0043-122237","volume":"50","author":"S Allelein","year":"2018","unstructured":"Allelein S, Ehlers M, Morneau C, Schwartz K, Goretzki PE, Seppel T et al (2018) Measurement of basal serum calcitonin for the diagnosis of medullary thyroid cancer. Horm Metab Res 50(1):23\u201328. https:\/\/doi.org\/10.1055\/s-0043-122237","journal-title":"Horm Metab Res"},{"issue":"2","key":"4_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1210\/jc.2015-3137","volume":"101","author":"TG Alves","year":"2016","unstructured":"Alves TG, Kasamatsu TS, Yang JH, Meneghetti MC, Mendes A, Kunii IS et al (2016) Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay. J Clin Endocrinol Metab 101(2):653\u2013658. https:\/\/doi.org\/10.1210\/jc.2015-3137","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"4_CR8","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1038\/s41379-020-0532-1","volume":"33","author":"B Alzumaili","year":"2020","unstructured":"Alzumaili B, Xu B, Spanheimer PM, Tuttle RM, Sherman E, Katabi N et al (2020) Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome. Mod Pathol 33(9):1690\u20131701. https:\/\/doi.org\/10.1038\/s41379-020-0532-1","journal-title":"Mod Pathol"},{"issue":"2","key":"4_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin 67(2):93\u201399. https:\/\/doi.org\/10.3322\/caac.21388","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"4_CR10","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/cancers11101516","volume":"11","author":"M Appetecchia","year":"2019","unstructured":"Appetecchia M, Lauretta R, Barnabei A, Pieruzzi L, Terrenato I, Cavedon E et al (2019) Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC\/PTC): an Italian Multicenter study. Cancers (Basel) 11(10):1516. https:\/\/doi.org\/10.3390\/cancers11101516","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4_CR11","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1210\/jc.2005-0044","volume":"90","author":"J Barbet","year":"2005","unstructured":"Barbet J, Campion L, Kraeber-Bodere F, Chatal JF, GTE Study Group (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90(11):6077\u20136084. https:\/\/doi.org\/10.1210\/jc.2005-0044","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4_CR12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","volume":"50","author":"JP Basuyau","year":"2004","unstructured":"Basuyau JP, Mallet E, Leroy M, Brunelle P (2004) Reference intervals for serum calcitonin in men, women, and children. Clin Chem 50(10):1828\u20131830. https:\/\/doi.org\/10.1373\/clinchem.2003.026963","journal-title":"Clin Chem"},{"issue":"4","key":"4_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr (2004) Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89(4):1512\u20131525. https:\/\/doi.org\/10.1210\/jc.2002-021444","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"4_CR14","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s40618-023-02115-2","volume":"46","author":"ZM Besharat","year":"2023","unstructured":"Besharat ZM, Trocchianesi S, Verrienti A, Ciampi R, Cantara S, Romei C et al (2023) Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients. J Endocrinol Investig 46(12):2583\u20132599. https:\/\/doi.org\/10.1007\/s40618-023-02115-2","journal-title":"J Endocrinol Investig"},{"issue":"5","key":"4_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/dc.20502","volume":"35","author":"P Bhanot","year":"2007","unstructured":"Bhanot P, Yang J, Schnadig VJ, Logrono R (2007) Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature. Diagn Cytopathol 35(5):285\u2013292. https:\/\/doi.org\/10.1002\/dc.20502","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"4_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/00000478-199106000-00009","volume":"15","author":"PW Biddinger","year":"1991","unstructured":"Biddinger PW, Brennan MF, Rosen PP (1991) Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Am J Surg Pathol 15(6):599\u2013604. https:\/\/doi.org\/10.1097\/00000478-199106000-00009","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cancers16030494","volume":"16","author":"T Binter","year":"2024","unstructured":"Binter T, Baumgartner-Parzer S, Schernthaner-Reiter MH, Arikan M, Hargitai L, Niederle MB et al (2024) Does genotype-specific phenotype in patients with multiple endocrine neoplasia type 2 occur as current guidelines predict? Cancers (Basel) 16(3):494. https:\/\/doi.org\/10.3390\/cancers16030494","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF03348671","volume":"15","author":"E Blind","year":"1992","unstructured":"Blind E, Raue F, Klaiber T, Zink A, Schroth J, Buhr H, Ziegler R (1992a) Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma. J Endocrinol Investig 15(2):93\u201398. https:\/\/doi.org\/10.1007\/BF03348671","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"4_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/thy.1992.2.5","volume":"2","author":"E Blind","year":"1992","unstructured":"Blind E, Schmidt-Gayk H, Sinn HP, O\u2019Connor DT, Raue F (1992b) Chromogranin a as tumor marker in medullary thyroid carcinoma. Thyroid 2(1):5\u201310. https:\/\/doi.org\/10.1089\/thy.1992.2.5","journal-title":"Thyroid"},{"issue":"6","key":"4_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/105072504323150813","volume":"14","author":"M Bockhorn","year":"2004","unstructured":"Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE (2004) Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14(6):468\u2013470. https:\/\/doi.org\/10.1089\/105072504323150813","journal-title":"Thyroid"},{"issue":"6","key":"4_CR21","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.surg.2010.09.011","volume":"148","author":"M Brauckhoff","year":"2010","unstructured":"Brauckhoff M, Machens A, Thanh PN, Lorenz K, Schmeil A, Stratmann M et al (2010) Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival. Surgery 148(6):1257\u20131266. https:\/\/doi.org\/10.1016\/j.surg.2010.09.011","journal-title":"Surgery"},{"issue":"6","key":"4_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"4_CR23","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/cancers15082333","volume":"15","author":"M Broecker-Preuss","year":"2023","unstructured":"Broecker-Preuss M, Simon D, Fries M, Kornely E, Weber M, Vardarli I et al (2023) Update on calcitonin screening for medullary thyroid carcinoma and the results of a retrospective analysis of 12,984 patients with thyroid nodules. Cancers (Basel) 15(8):2333. https:\/\/doi.org\/10.3390\/cancers15082333","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1210\/jc.2014-3095","volume":"100","author":"EF Brutsaert","year":"2015","unstructured":"Brutsaert EF, Gersten AJ, Tassler AB, Surks MI (2015) Medullary thyroid cancer with undetectable serum calcitonin. J Clin Endocrinol Metab 100(2):337\u2013341. https:\/\/doi.org\/10.1210\/jc.2014-3095","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR25","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/ERC-17-0209","volume":"25","author":"F Castinetti","year":"2018","unstructured":"Castinetti F, Moley J, Mulligan L, Waguespack SG (2018) A comprehensive review on MEN2B. Endocr Relat Cancer 25(2):T29\u2013T39. https:\/\/doi.org\/10.1530\/ERC-17-0209","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"4_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","volume":"7","author":"F Castinetti","year":"2019","unstructured":"Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G et al (2019) Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol 7(3):213\u2013220. https:\/\/doi.org\/10.1016\/S2213-8587(18)30336-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.647369","volume":"12","author":"S Censi","year":"2021","unstructured":"Censi S, Bertazza L, Piva I, Manso J, Benna C, Iacobone M et al (2021a) Serum miR-375 for diagnostic and prognostic purposes in medullary thyroid carcinoma. Front Endocrinol (Lausanne) 12:647369. https:\/\/doi.org\/10.3389\/fendo.2021.647369","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.754565","volume":"12","author":"S Censi","year":"2021","unstructured":"Censi S, Di Stefano M, Repaci A, Benvenuti T, Manso J, Pagotto U et al (2021b) Basal and calcium-stimulated Procalcitonin for the diagnosis of medullary thyroid cancers: lights and shadows. Front Endocrinol (Lausanne) 12:754565. https:\/\/doi.org\/10.3389\/fendo.2021.754565","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"4_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2023.0482","volume":"34","author":"S Censi","year":"2024","unstructured":"Censi S, Galuppini F, Clausi C, Battheu F, Manso J, Piva I et al (2024) Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma. Thyroid 34(2):177\u2013185. https:\/\/doi.org\/10.1089\/thy.2023.0482","journal-title":"Thyroid"},{"issue":"1","key":"4_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/jc.2010-0162","volume":"96","author":"G Chambon","year":"2011","unstructured":"Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM et al (2011) The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96(1):75\u201381. https:\/\/doi.org\/10.1210\/jc.2010-0162","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002420","volume":"8","author":"SK Choi","year":"2012","unstructured":"Choi SK, Yoon SR, Calabrese P, Arnheim N (2012) Positive selection for new disease mutations in the human germline: evidence from the heritable cancer syndrome multiple endocrine neoplasia type 2B. PLoS Genet 8(2):e1002420. https:\/\/doi.org\/10.1371\/journal.pgen.1002420","journal-title":"PLoS Genet"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.isci.2019.09.030","volume":"20","author":"R Ciampi","year":"2019","unstructured":"Ciampi R, Romei C, Ramone T, Prete A, Tacito A, Cappagli V et al (2019) Genetic landscape of somatic mutations in a large cohort of sporadic medullary thyroid carcinomas studied by next-generation targeted sequencing. iScience 20:324\u2013336. https:\/\/doi.org\/10.1016\/j.isci.2019.09.030","journal-title":"iScience"},{"issue":"3","key":"4_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cncy.22365","volume":"129","author":"AM Ciarletto","year":"2021","unstructured":"Ciarletto AM, Narick C, Malchoff CD, Massoll NA, Labourier E, Haugh K et al (2021) Analytical and clinical validation of pairwise microRNA expression analysis to identify medullary thyroid cancer in thyroid fine-needle aspiration samples. Cancer Cytopathol 129(3):239\u2013249. https:\/\/doi.org\/10.1002\/cncy.22365","journal-title":"Cancer Cytopathol"},{"issue":"11","key":"4_CR34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","volume":"27","author":"ES Cibas","year":"2017","unstructured":"Cibas ES, Ali SZ (2017) The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 27(11):1341\u20131346. https:\/\/doi.org\/10.1089\/thy.2017.0500","journal-title":"Thyroid"},{"issue":"2","key":"4_CR35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"R Cohen","year":"2000","unstructured":"Cohen R, Campos JM, Salaun C, Heshmati HM, Kraimps JL, Proye C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85(2):919\u2013922. https:\/\/doi.org\/10.1210\/jcem.85.2.6556","journal-title":"J Clin Endocrinol Metab"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-015-0231-z","volume":"10","author":"C Colombo","year":"2015","unstructured":"Colombo C, Minna E, Rizzetti MG, Romeo P, Lecis D, Persani L et al (2015) The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression\/penetrance studies. Orphanet J Rare Dis 10:25. https:\/\/doi.org\/10.1186\/s13023-015-0231-z","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"4_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S et al (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92(2):450\u2013455. https:\/\/doi.org\/10.1210\/jc.2006-1590","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/er.2006-0017","volume":"27","author":"JW de Groot","year":"2006","unstructured":"de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM (2006) RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 27(5):535\u2013560. https:\/\/doi.org\/10.1210\/er.2006-0017","journal-title":"Endocr Rev"},{"issue":"7","key":"4_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","volume":"2","author":"H Donis-Keller","year":"1993","unstructured":"Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2(7):851\u2013856. https:\/\/doi.org\/10.1093\/hmg\/2.7.851","journal-title":"Hum Mol Genet"},{"issue":"8","key":"4_CR40","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/thy.2007.0231","volume":"18","author":"JM Dora","year":"2008","unstructured":"Dora JM, Canalli MH, Capp C, Punales MK, Vieira JG, Maia AL (2008) Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid 18(8):895\u2013899. https:\/\/doi.org\/10.1089\/thy.2007.0231","journal-title":"Thyroid"},{"issue":"6","key":"4_CR41","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.surg.2023.09.003","volume":"174","author":"H Dralle","year":"2023","unstructured":"Dralle H, Brandenburg T, Weber F, Fuhrer-Sakel D, Theurer S, Baba HA et al (2023) Sporadic noninvasive medullary thyroid neoplasm: a desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy. Surgery 174(6):1356\u20131362. https:\/\/doi.org\/10.1016\/j.surg.2023.09.003","journal-title":"Surgery"},{"issue":"5","key":"4_CR42","doi-asserted-by":"publisher","first-page":"e230067","DOI":"10.1530\/ETJ-23-0067","volume":"12","author":"C Durante","year":"2023","unstructured":"Durante C, Hegedus L, Czarniecka A, Paschke R, Russ G, Schmitt F et al (2023) 2023 European thyroid association clinical practice guidelines for thyroid nodule management. Eur Thyroid J 12(5):e230067. https:\/\/doi.org\/10.1530\/ETJ-23-0067","journal-title":"Eur Thyroid J"},{"issue":"1","key":"4_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/thy.2022.0295","volume":"33","author":"M Duval","year":"2023","unstructured":"Duval M, Ferreira CV, Marmitt L, Dora JM, Espindola M, Benini AF et al (2023) An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma: results of a retrospective cohort study. Thyroid 33(1):82\u201390. https:\/\/doi.org\/10.1089\/thy.2022.0295","journal-title":"Thyroid"},{"issue":"8","key":"4_CR44","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1515\/cclm-2018-1186","volume":"57","author":"F Eckelt","year":"2019","unstructured":"Eckelt F, Vogel M, Geserick M, Kirsten T, Bae YJ, Baber R et al (2019) Calcitonin measurement in pediatrics: reference ranges are gender-dependent, validation in medullary thyroid cancer and thyroid diseases. Clin Chem Lab Med 57(8):1242\u20131250. https:\/\/doi.org\/10.1515\/cclm-2018-1186","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"4_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1210\/jc.2003-030550","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89(1):163\u2013168. https:\/\/doi.org\/10.1210\/jc.2003-030550","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4_CR46","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1210\/jc.2007-1714","volume":"93","author":"R Elisei","year":"2008","unstructured":"Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E et al (2008) Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 93(3):682\u2013687. https:\/\/doi.org\/10.1210\/jc.2007-1714","journal-title":"J Clin Endocrinol Metab"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"1141314","DOI":"10.3389\/fonc.2023.1141314","volume":"13","author":"R Elisei","year":"2023","unstructured":"Elisei R, Grande E, Kreissl MC, Leboulleux S, Puri T, Fasnacht N, Capdevila J (2023) Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe. Front Oncol 13:1141314. https:\/\/doi.org\/10.3389\/fonc.2023.1141314","journal-title":"Front Oncol"},{"issue":"12","key":"4_CR48","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2007-1005","volume":"92","author":"R Elisei","year":"2007","unstructured":"Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E et al (2007) RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab 92(12):4725\u20134729. https:\/\/doi.org\/10.1210\/jc.2007-1005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2265.1995.tb01903.x","volume":"43","author":"C Eng","year":"1995","unstructured":"Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F et al (1995) Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol 43(1):123\u2013127. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01903.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"4_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.gastrohep.2017.01.005","volume":"41","author":"A Ernaga Lorea","year":"2018","unstructured":"Ernaga Lorea A, Migueliz Bermejo I, Eguilaz Esparza N, Hernandez Morhain MC, Pineda Arribas J (2018) Chronic diarrhea: the first symptom of a metastatic medullary thyroid carcinoma. Gastroenterol Hepatol 41(2):105\u2013107. https:\/\/doi.org\/10.1016\/j.gastrohep.2017.01.005","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"4_CR51","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.5858\/132.11.1767","volume":"132","author":"D Etit","year":"2008","unstructured":"Etit D, Faquin WC, Gaz R, Randolph G, DeLellis RA, Pilch BZ (2008) Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases. Arch Pathol Lab Med 132(11):1767\u20131773. https:\/\/doi.org\/10.5858\/132.11.1767","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"4_CR52","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/bjs\/znab106","volume":"108","author":"F Fanget","year":"2021","unstructured":"Fanget F, Demarchi MS, Maillard L, Lintis A, Decaussin M, Lifante JC (2021) Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels. Br J Surg 108(9):1064\u20131071. https:\/\/doi.org\/10.1093\/bjs\/znab106","journal-title":"Br J Surg"},{"issue":"5","key":"4_CR53","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/cen.14739","volume":"97","author":"G Ferrarazzo","year":"2022","unstructured":"Ferrarazzo G, Camponovo C, Deandrea M, Piccardo A, Scappaticcio L, Trimboli P (2022) Suboptimal accuracy of ultrasound and ultrasound-based risk stratification systems in detecting medullary thyroid carcinoma should not be overlooked. Findings from a systematic review with meta-analysis. Clin Endocrinol 97(5):532\u2013540. https:\/\/doi.org\/10.1111\/cen.14739","journal-title":"Clin Endocrinol"},{"issue":"1","key":"4_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2012.09.002","volume":"752","author":"G Figlioli","year":"2013","unstructured":"Figlioli G, Landi S, Romei C, Elisei R, Gemignani F (2013) Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res 752(1):36\u201344. https:\/\/doi.org\/10.1016\/j.mrrev.2012.09.002","journal-title":"Mutat Res"},{"issue":"12","key":"4_CR55","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K et al (2019) Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 30(12):1856\u20131883. https:\/\/doi.org\/10.1093\/annonc\/mdz400","journal-title":"Ann Oncol"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"20-0207","DOI":"10.1530\/EDM-20-0207","volume":"2021","author":"HE Forde","year":"2021","unstructured":"Forde HE, Mehigan-Farrelly N, Ryan K, Moran T, Greally M, Duffy AG, Byrne MM (2021) Metastatic medullary thyroid carcinoma presenting as ectopic Cushing\u2019s syndrome. Endocrinol Diabetes Metab Case Rep 2021:20-0207. https:\/\/doi.org\/10.1530\/EDM-20-0207","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"4_CR57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(sici)1097-0142(19981025)84:5<295::aid-cncr5>3.0.co;2-j","volume":"84","author":"CH Forrest","year":"1998","unstructured":"Forrest CH, Frost FA, de Boer WB, Spagnolo DV, Whitaker D, Sterrett BF (1998) Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer 84(5):295\u2013302. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981025)84:5<295::aid-cncr5>3.0.co;2-j","journal-title":"Cancer"},{"issue":"2","key":"4_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/eje.1.02216","volume":"155","author":"K Frank-Raue","year":"2006","unstructured":"Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T et al (2006) Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155(2):229\u2013236. https:\/\/doi.org\/10.1530\/eje.1.02216","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4_CR59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/thy.2012.0236","volume":"23","author":"K Frank-Raue","year":"2013","unstructured":"Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E et al (2013) Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid 23(3):294\u2013300. https:\/\/doi.org\/10.1089\/thy.2012.0236","journal-title":"Thyroid"},{"issue":"10","key":"4_CR60","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","volume":"44","author":"TL Fuchs","year":"2020","unstructured":"Fuchs TL, Nassour AJ, Glover A, Sywak MS, Sidhu SB, Delbridge LW et al (2020) A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis. Am J Surg Pathol 44(10):1419\u20131428. https:\/\/doi.org\/10.1097\/PAS.0000000000001505","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"4_CR61","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40618-020-01356-9","volume":"44","author":"L Fugazzola","year":"2021","unstructured":"Fugazzola L, Di Stefano M, Censi S, Repaci A, Colombo C, Grimaldi F et al (2021) Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment. J Endocrinol Investig 44(3):587\u2013597. https:\/\/doi.org\/10.1007\/s40618-020-01356-9","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"4_CR62","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/cen.14060","volume":"91","author":"JM Fussey","year":"2019","unstructured":"Fussey JM, Vaidya B, Kim D, Clark J, Ellard S, Smith JA (2019) The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: a systematic review. Clin Endocrinol 91(6):697\u2013707. https:\/\/doi.org\/10.1111\/cen.14060","journal-title":"Clin Endocrinol"},{"issue":"4","key":"4_CR63","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/cells10040955","volume":"10","author":"F Galuppini","year":"2021","unstructured":"Galuppini F, Censi S, Moro M, Carraro S, Sbaraglia M, Iacobone M et al (2021) MicroRNAs in medullary thyroid carcinoma: a state of the art review of the regulatory mechanisms and future perspectives. Cells 10(4):955. https:\/\/doi.org\/10.3390\/cells10040955","journal-title":"Cells"},{"issue":"1","key":"4_CR64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12902-019-0435-7","volume":"19","author":"C Gambardella","year":"2019","unstructured":"Gambardella C, Offi C, Clarizia G, Romano RM, Cozzolino I, Montella M et al (2019) Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review. BMC Endocr Disord 19(1):103. https:\/\/doi.org\/10.1186\/s12902-019-0435-7","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"4_CR65","doi-asserted-by":"publisher","first-page":"622","DOI":"10.4158\/EP161208.GL","volume":"22","author":"H Gharib","year":"2016","unstructured":"Gharib H, Papini E, Garber JR, Duick DS, Harrell RM, Hegedus L et al (2016) American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules\u20142016 update. Endocr Pract 22(5):622\u2013639. https:\/\/doi.org\/10.4158\/EP161208.GL","journal-title":"Endocr Pract"},{"issue":"6","key":"4_CR66","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1530\/EJE-20-0506","volume":"183","author":"E Giannetta","year":"2020","unstructured":"Giannetta E, Guarnotta V, Altieri B, Sciammarella C, Guadagno E, Malandrino P et al (2020) ENDOCRINE TUMOURS: calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus. Eur J Endocrinol 183(6):R197\u2013R215. https:\/\/doi.org\/10.1530\/EJE-20-0506","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"4_CR67","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1210\/clinem\/dgab564","volume":"106","author":"L Giovanella","year":"2021","unstructured":"Giovanella L, Garo ML, Ceriani L, Paone G, Campenni A, D\u2019Aurizio F (2021) Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. J Clin Endocrinol Metab 106(12):3634\u20133643. https:\/\/doi.org\/10.1210\/clinem\/dgab564","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00259-019-04458-6","volume":"47","author":"L Giovanella","year":"2020","unstructured":"Giovanella L, Treglia G, Iakovou I, Mihailovic J, Verburg FA, Luster M (2020) EANM practice guideline for PET\/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 47(1):61\u201377. https:\/\/doi.org\/10.1007\/s00259-019-04458-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"4_CR69","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1210\/jc.2007-1211","volume":"92","author":"AL Giraudet","year":"2007","unstructured":"Giraudet AL, Vanel D, Leboulleux S, Auperin A, Dromain C, Chami L et al (2007) Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 92(11):4185\u20134190. https:\/\/doi.org\/10.1210\/jc.2007-1211","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"4_CR70","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/bjs\/znad172","volume":"110","author":"J Gomez-Ramirez","year":"2023","unstructured":"Gomez-Ramirez J, Luengo P, Mercader E, Quintana A, Munoz de Nova JL, Febrero B et al (2023) Desmoplastic reaction in medullary thyroid carcinoma predicts presence of lymph node metastasis. Br J Surg 110(8):1011\u20131012. https:\/\/doi.org\/10.1093\/bjs\/znad172","journal-title":"Br J Surg"},{"issue":"6","key":"4_CR71","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/BF00390873","volume":"113","author":"A Grauer","year":"1987","unstructured":"Grauer A, Raue F, Rix E, Tschahargane C, Ziegler R (1987) Neuron-specific enolase in medullary thyroid carcinoma: immunohistochemical demonstration, but no significance as serum tumor marker. J Cancer Res Clin Oncol 113(6):599\u2013602. https:\/\/doi.org\/10.1007\/BF00390873","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"4_CR72","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/thy.1995.5.287","volume":"5","author":"A Grauer","year":"1995","unstructured":"Grauer A, Schroth J, Ziegler R, Raue F (1995) Evaluation of somatostatin as a plasma tumor marker in medullary thyroid carcinoma. Thyroid 5(4):287\u2013291. https:\/\/doi.org\/10.1089\/thy.1995.5.287","journal-title":"Thyroid"},{"issue":"7","key":"4_CR73","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/CM9.0000000000000160","volume":"132","author":"QQ Guo","year":"2019","unstructured":"Guo QQ, Zhang SH, Niu LJ, Zhang YK, Li ZJ, Chang Q (2019) Comprehensive evaluation of medullary thyroid carcinoma before surgery. Chin Med J 132(7):834\u2013841. https:\/\/doi.org\/10.1097\/CM9.0000000000000160","journal-title":"Chin Med J"},{"issue":"1","key":"4_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/jcem.82.1.3684","volume":"82","author":"S Guyetant","year":"1997","unstructured":"Guyetant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-Andre JP (1997) Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82(1):42\u201347. https:\/\/doi.org\/10.1210\/jcem.82.1.3684","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2213-8587(15)00337-X","volume":"4","author":"J Hadoux","year":"2016","unstructured":"Hadoux J, Pacini F, Tuttle RM, Schlumberger M (2016) Management of advanced medullary thyroid cancer. Lancet Diabetes Endocrinol 4(1):64\u201371. https:\/\/doi.org\/10.1016\/S2213-8587(15)00337-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"4_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"1","key":"4_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/jcem-19-1-152","volume":"19","author":"JB Hazard","year":"1959","unstructured":"Hazard JB, Hawk WA, Crile G Jr (1959) Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab 19(1):152\u2013161. https:\/\/doi.org\/10.1210\/jcem-19-1-152","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"4_CR78","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.3390\/cancers15072125","volume":"15","author":"M Holm","year":"2023","unstructured":"Holm M, Vestergaard P, Poulsen MM, Rasmussen AK, Feldt-Rasmussen U, Bay M et al (2023) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A in Denmark 1930\u20132021: a Nationwide population-based retrospective study. Cancers (Basel) 15(7):2125. https:\/\/doi.org\/10.3390\/cancers15072125","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1677\/erc.0.0110357","volume":"11","author":"SI Ismailov","year":"2004","unstructured":"Ismailov SI, Piulatova NR (2004) Postoperative calcitonin study in medullary thyroid carcinoma. Endocr Relat Cancer 11(2):357\u2013363. https:\/\/doi.org\/10.1677\/erc.0.0110357","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"4_CR80","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.21037\/qims-22-968","volume":"13","author":"L Jiang","year":"2023","unstructured":"Jiang L, Zhu HB, Liang ZW, Chen L, Sun XM, Shao YH, Chen LZ (2023) Comparison of the diagnostic performance and clinical role of different ultrasound-based thyroid malignancy risk stratification systems for medullary thyroid carcinoma. Quant Imaging Med Surg 13(6):3776\u20133788. https:\/\/doi.org\/10.21037\/qims-22-968","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"4_CR81","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cncr.29761","volume":"122","author":"LX Jin","year":"2016","unstructured":"Jin LX, Moley JF (2016) Surgery for lymph node metastases of medullary thyroid carcinoma: a review. Cancer 122(3):358\u2013366. https:\/\/doi.org\/10.1002\/cncr.29761","journal-title":"Cancer"},{"issue":"20","key":"4_CR82","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1242\/dev.126581","volume":"142","author":"E Johansson","year":"2015","unstructured":"Johansson E, Andersson L, Ornros J, Carlsson T, Ingeson-Carlsson C, Liang S et al (2015) Revising the embryonic origin of thyroid C cells in mice and humans. Development 142(20):3519\u20133528. https:\/\/doi.org\/10.1242\/dev.126581","journal-title":"Development"},{"issue":"9","key":"4_CR83","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1373\/clinchem.2016.270009","volume":"63","author":"GJ Kahaly","year":"2017","unstructured":"Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S et al (2017) United States and European Multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem 63(9):1489\u20131496. https:\/\/doi.org\/10.1373\/clinchem.2016.270009","journal-title":"Clin Chem"},{"issue":"2","key":"4_CR84","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/jc.2003-030709","volume":"89","author":"G Karanikas","year":"2004","unstructured":"Karanikas G, Moameni A, Poetzi C, Zettinig G, Kaserer K, Bieglmayer C et al (2004) Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89(2):515\u2013519. https:\/\/doi.org\/10.1210\/jc.2003-030709","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR85","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-2004-815727","volume":"112","author":"W Karges","year":"2004","unstructured":"Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M et al (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112(1):52\u201358. https:\/\/doi.org\/10.1055\/s-2004-815727","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"4_CR86","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/00000478-200110000-00004","volume":"25","author":"K Kaserer","year":"2001","unstructured":"Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Haas OA, Vierhapper H, Niederle B (2001) Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol 25(10):1245\u20131251. https:\/\/doi.org\/10.1097\/00000478-200110000-00004","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"4_CR87","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1210\/en.2004-0780","volume":"145","author":"R Khurana","year":"2004","unstructured":"Khurana R, Agarwal A, Bajpai VK, Verma N, Sharma AK, Gupta RP, Madhusudan KP (2004) Unraveling the amyloid associated with human medullary thyroid carcinoma. Endocrinology 145(12):5465\u20135470. https:\/\/doi.org\/10.1210\/en.2004-0780","journal-title":"Endocrinology"},{"issue":"11","key":"4_CR88","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41574-020-00414-9","volume":"16","author":"CM Kitahara","year":"2020","unstructured":"Kitahara CM, Sosa JA (2020) Understanding the ever-changing incidence of thyroid cancer. Nat Rev Endocrinol 16(11):617\u2013618. https:\/\/doi.org\/10.1038\/s41574-020-00414-9","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"4_CR89","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/cen.14617","volume":"96","author":"VF Koehler","year":"2022","unstructured":"Koehler VF, Fuss CT, Berr CM, Frank-Raue K, Raue F, Hoster E et al (2022) Medullary thyroid cancer with ectopic Cushing\u2019s syndrome: a multicentre case series. Clin Endocrinol 96(6):847\u2013856. https:\/\/doi.org\/10.1111\/cen.14617","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4_CR90","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1373\/clinchem.2010.151688","volume":"57","author":"J Kratzsch","year":"2011","unstructured":"Kratzsch J, Petzold A, Raue F, Reinhardt W, Brocker-Preuss M, Gorges R et al (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57(3):467\u2013474. https:\/\/doi.org\/10.1373\/clinchem.2010.151688","journal-title":"Clin Chem"},{"issue":"11","key":"4_CR91","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1515\/cclm-2021-0428","volume":"59","author":"J Kratzsch","year":"2021","unstructured":"Kratzsch J, Willenberg A, Frank-Raue K, Kempin U, Rocktaschel J, Raue F (2021) Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma. Clin Chem Lab Med 59(11):1861\u20131868. https:\/\/doi.org\/10.1515\/cclm-2021-0428","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"4_CR92","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/thy.2006.0338","volume":"17","author":"T Kudo","year":"2007","unstructured":"Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M (2007) Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17(7):635\u2013638. https:\/\/doi.org\/10.1089\/thy.2006.0338","journal-title":"Thyroid"},{"issue":"2","key":"4_CR93","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1530\/EJE-07-0667","volume":"158","author":"A Laure Giraudet","year":"2008","unstructured":"Laure Giraudet A, Al Ghulzan A, Auperin A, Leboulleux S, Chehboun A, Troalen F et al (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 158(2):239\u2013246. https:\/\/doi.org\/10.1530\/EJE-07-0667","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"4_CR94","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2214\/AJR.09.3276","volume":"194","author":"S Lee","year":"2010","unstructured":"Lee S, Shin JH, Han BK, Ko EY (2010) Medullary thyroid carcinoma: comparison with papillary thyroid carcinoma and application of current sonographic criteria. AJR Am J Roentgenol 194(4):1090\u20131094. https:\/\/doi.org\/10.2214\/AJR.09.3276","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"4_CR95","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA 317(13):1338\u20131348. https:\/\/doi.org\/10.1001\/jama.2017.2719","journal-title":"JAMA"},{"issue":"2","key":"4_CR96","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2014.0277","volume":"25","author":"SC Lindsey","year":"2015","unstructured":"Lindsey SC, Ganly I, Palmer F, Tuttle RM (2015) Response to initial therapy predicts clinical outcomes in medullary thyroid cancer. Thyroid 25(2):242\u2013249. https:\/\/doi.org\/10.1089\/thy.2014.0277","journal-title":"Thyroid"},{"issue":"2","key":"4_CR97","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12022-021-09672-3","volume":"32","author":"VA Livolsi","year":"2021","unstructured":"Livolsi VA (2021) Neuroendocrine tumors of the thyroid and their mimics. Endocr Pathol 32(2):211\u2013221. https:\/\/doi.org\/10.1007\/s12022-021-09672-3","journal-title":"Endocr Pathol"},{"issue":"1","key":"4_CR98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12902-023-01409-z","volume":"23","author":"T Ma","year":"2023","unstructured":"Ma T, Wang R, Zhou X, Liu L, Pan A, Wang H, Huang L (2023) Case reports of collision and composite carcinomas of the thyroid: an insight into their origin and clinical significance. BMC Endocr Disord 23(1):173. https:\/\/doi.org\/10.1186\/s12902-023-01409-z","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"4_CR99","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1210\/jc.2009-2368","volume":"95","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H (2010a) Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95(6):2655\u20132663. https:\/\/doi.org\/10.1210\/jc.2009-2368","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/EJE-10-0203","volume":"163","author":"A Machens","year":"2010","unstructured":"Machens A, Dralle H (2010b) Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995\u20132009. Eur J Endocrinol 163(1):111\u2013119. https:\/\/doi.org\/10.1530\/EJE-10-0203","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"4_CR101","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/SLA.0b013e31826bc239","volume":"257","author":"A Machens","year":"2013","unstructured":"Machens A, Dralle H (2013) Benefit-risk balance of reoperation for persistent medullary thyroid cancer. Ann Surg 257(4):751\u2013757. https:\/\/doi.org\/10.1097\/SLA.0b013e31826bc239","journal-title":"Ann Surg"},{"issue":"6","key":"4_CR102","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1210\/jc.2007-2792","volume":"93","author":"A Machens","year":"2008","unstructured":"Machens A, Hauptmann S, Dralle H (2008) Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 93(6):2234\u20132238. https:\/\/doi.org\/10.1210\/jc.2007-2792","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR103","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00268-001-0176-3","volume":"26","author":"A Machens","year":"2002","unstructured":"Machens A, Hinze R, Thomusch O, Dralle H (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26(1):22\u201328. https:\/\/doi.org\/10.1007\/s00268-001-0176-3","journal-title":"World J Surg"},{"issue":"4","key":"4_CR104","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1677\/ERC-09-0136","volume":"16","author":"A Machens","year":"2009","unstructured":"Machens A, Hoffmann F, Sekulla C, Dralle H (2009) Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. Endocr Relat Cancer 16(4):1291\u20131298. https:\/\/doi.org\/10.1677\/ERC-09-0136","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"4_CR105","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1067\/s0039-6060(03)00157-0","volume":"134","author":"A Machens","year":"2003","unstructured":"Machens A, Holzhausen HJ, Thanh PN, Dralle H (2003) Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 134(3):425\u2013431. https:\/\/doi.org\/10.1067\/s0039-6060(03)00157-0","journal-title":"Surgery"},{"issue":"2","key":"4_CR106","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.surg.2021.07.035","volume":"171","author":"A Machens","year":"2022","unstructured":"Machens A, Kaatzsch P, Lorenz K, Horn LC, Wickenhauser C, Schmid KW et al (2022) Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer. Surgery 171(2):360\u2013367. https:\/\/doi.org\/10.1016\/j.surg.2021.07.035","journal-title":"Surgery"},{"issue":"8","key":"4_CR107","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1210\/jc.2014-1278","volume":"99","author":"A Machens","year":"2014","unstructured":"Machens A, Lorenz K, Dralle H (2014) Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. J Clin Endocrinol Metab 99(8):2986\u20132994. https:\/\/doi.org\/10.1210\/jc.2014-1278","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4_CR108","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/bjs.11071","volume":"106","author":"A Machens","year":"2019","unstructured":"Machens A, Lorenz K, Dralle H (2019) Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer. Br J Surg 106(4):412\u2013418. https:\/\/doi.org\/10.1002\/bjs.11071","journal-title":"Br J Surg"},{"issue":"3","key":"4_CR109","doi-asserted-by":"publisher","first-page":"289-293; discus","DOI":"10.1001\/archsurg.142.3.289","volume":"142","author":"A Machens","year":"2007","unstructured":"Machens A, Ukkat J, Hauptmann S, Dralle H (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 142(3):289-293; discussion 294. https:\/\/doi.org\/10.1001\/archsurg.142.3.289","journal-title":"Arch Surg"},{"issue":"12","key":"4_CR110","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/humu.24486","volume":"43","author":"RL Margraf","year":"2022","unstructured":"Margraf RL, Alexander RZ, Fulmer ML, Miller CE, Coupal E, Mao R (2022) Multiple endocrine neoplasia type 2 (MEN2) and RET specific modifications of the ACMG\/AMP variant classification guidelines and impact on the MEN2 RET database. Hum Mutat 43(12):1780\u20131794. https:\/\/doi.org\/10.1002\/humu.24486","journal-title":"Hum Mutat"},{"issue":"6130","key":"4_CR111","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/328527a0","volume":"328","author":"CG Mathew","year":"1987","unstructured":"Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI et al (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328(6130):527\u2013528. https:\/\/doi.org\/10.1038\/328527a0","journal-title":"Nature"},{"key":"4_CR112","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","volume":"79","author":"JS Mathiesen","year":"2022","unstructured":"Mathiesen JS, Effraimidis G, Rossing M, Rasmussen AK, Hoejberg L, Bastholt L et al (2022) Multiple endocrine neoplasia type 2: a review. Semin Cancer Biol 79:163\u2013179. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.035","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"4_CR113","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1210\/jc.2016-3640","volume":"102","author":"JS Mathiesen","year":"2017","unstructured":"Mathiesen JS, Habra MA, Bassett JHD, Choudhury SM, Balasubramanian SP, Howlett TA et al (2017) Risk profile of the RET A883F germline mutation: an international collaborative study. J Clin Endocrinol Metab 102(6):2069\u20132074. https:\/\/doi.org\/10.1210\/jc.2016-3640","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4_CR114","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1530\/EC-18-0157","volume":"7","author":"JS Mathiesen","year":"2018","unstructured":"Mathiesen JS, Kroustrup JP, Vestergaard P, Stochholm K, Poulsen PL, Rasmussen AK et al (2018) Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study. Endocr Connect 7(6):829\u2013839. https:\/\/doi.org\/10.1530\/EC-18-0157","journal-title":"Endocr Connect"},{"issue":"4","key":"4_CR115","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2265.2009.03666.x","volume":"72","author":"JA Meijer","year":"2010","unstructured":"Meijer JA, le Cessie S, van den Hout WB, Kievit J, Schoones JW, Romijn JA, Smit JW (2010) Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clin Endocrinol 72(4):534\u2013542. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03666.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"4_CR116","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/1097-0142(1984)54:4<657::aid-cncr2820540412>3.0.co;2-v","volume":"54","author":"G Mendelsohn","year":"1984","unstructured":"Mendelsohn G, Wells SA Jr, Baylin SB (1984) Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease. Cancer 54(4):657\u2013662. https:\/\/doi.org\/10.1002\/1097-0142(1984)54:4<657::aid-cncr2820540412>3.0.co;2-v","journal-title":"Cancer"},{"issue":"6","key":"4_CR117","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1530\/EJE-11-0079","volume":"164","author":"C Mian","year":"2011","unstructured":"Mian C, Pennelli G, Barollo S, Cavedon E, Nacamulli D, Vianello F et al (2011) Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol 164(6):971\u2013976. https:\/\/doi.org\/10.1530\/EJE-11-0079","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"4_CR118","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/jc.2013-4088","volume":"99","author":"C Mian","year":"2014","unstructured":"Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S et al (2014) Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. J Clin Endocrinol Metab 99(5):1656\u20131664. https:\/\/doi.org\/10.1210\/jc.2013-4088","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4_CR119","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2004-1500","volume":"90","author":"E Mirallie","year":"2005","unstructured":"Mirallie E, Vuillez JP, Bardet S, Frampas E, Dupas B, Ferrer L et al (2005) High frequency of bone\/bone marrow involvement in advanced medullary thyroid cancer. J Clin Endocrinol Metab 90(2):779\u2013788. https:\/\/doi.org\/10.1210\/jc.2004-1500","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"4_CR120","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","volume":"229","author":"JF Moley","year":"1999","unstructured":"Moley JF, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229(6):880\u2013887; discussion 887-888. https:\/\/doi.org\/10.1097\/00000658-199906000-00016","journal-title":"Ann Surg"},{"issue":"4","key":"4_CR121","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cen.13386","volume":"87","author":"L Mucha","year":"2017","unstructured":"Mucha L, Leidig-Bruckner G, Frank-Raue K, Bruckner T, Kroiss M, Raue F, German study group for rare thyroid cancer (2017) Phaeochromocytoma in multiple endocrine neoplasia type 2: RET codon-specific penetrance and changes in management during the last four decades. Clin Endocrinol 87(4):320\u2013326. https:\/\/doi.org\/10.1111\/cen.13386","journal-title":"Clin Endocrinol"},{"issue":"3","key":"4_CR122","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc3680","volume":"14","author":"LM Mulligan","year":"2014","unstructured":"Mulligan LM (2014) RET revisited: expanding the oncogenic portfolio. Nat Rev Cancer 14(3):173\u2013186. https:\/\/doi.org\/10.1038\/nrc3680","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4_CR123","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1530\/eje.0.1410468","volume":"141","author":"P Niccoli-Sire","year":"1999","unstructured":"Niccoli-Sire P, Murat A, Baudin E, Henry JF, Proye C, Bigorgne JC et al (1999) Early or prophylactic thyroidectomy in MEN 2\/FMTC gene carriers: results in 71 thyroidectomized patients. The French calcitonin Tumours study group (GETC). Eur J Endocrinol 141(5):468\u2013474. https:\/\/doi.org\/10.1530\/eje.0.1410468","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4_CR124","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/bjs\/znaa047","volume":"108","author":"MB Niederle","year":"2021","unstructured":"Niederle MB, Riss P, Selberherr A, Koperek O, Kaserer K, Niederle B, Scheuba C (2021) Omission of lateral lymph node dissection in medullary thyroid cancer without a desmoplastic stromal reaction. Br J Surg 108(2):174\u2013181. https:\/\/doi.org\/10.1093\/bjs\/znaa047","journal-title":"Br J Surg"},{"issue":"7","key":"4_CR125","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/thy.2019.0785","volume":"30","author":"MB Niederle","year":"2020","unstructured":"Niederle MB, Scheuba C, Riss P, Selberherr A, Koperek O, Niederle B (2020) Early diagnosis of medullary thyroid cancer: are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays? Thyroid 30(7):974\u2013984. https:\/\/doi.org\/10.1089\/thy.2019.0785","journal-title":"Thyroid"},{"issue":"4","key":"4_CR126","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000450680","volume":"5","author":"M Nilsson","year":"2016","unstructured":"Nilsson M, Williams ED (2016) Medullary thyroid carcinoma\u2014distinction towards neuroectodermal tumours: reply to the letter by Paschou and Vryonidou. Eur Thyroid J 5(4):279\u2013280. https:\/\/doi.org\/10.1159\/000450680","journal-title":"Eur Thyroid J"},{"issue":"4","key":"4_CR127","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2967\/jnumed.106.036681","volume":"48","author":"SC Ong","year":"2007","unstructured":"Ong SC, Schoder H, Patel SG, Tabangay-Lim IM, Doddamane I, Gonen M et al (2007) Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48(4):501\u2013507. https:\/\/doi.org\/10.2967\/jnumed.106.036681","journal-title":"J Nucl Med"},{"issue":"3","key":"4_CR128","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000499018","volume":"8","author":"EM Opsahl","year":"2019","unstructured":"Opsahl EM, Akslen LA, Schlichting E, Aas T, Brauckhoff K, Hagen AI et al (2019) The role of calcitonin in predicting the extent of surgery in medullary thyroid carcinoma: a nationwide population-based study in Norway. Eur Thyroid J 8(3):159\u2013166. https:\/\/doi.org\/10.1159\/000499018","journal-title":"Eur Thyroid J"},{"issue":"4","key":"4_CR129","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1242\/dev.119.4.1005","volume":"119","author":"V Pachnis","year":"1993","unstructured":"Pachnis V, Mankoo B, Costantini F (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119(4):1005\u20131017. https:\/\/doi.org\/10.1242\/dev.119.4.1005","journal-title":"Development"},{"issue":"7","key":"4_CR130","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","volume":"41","author":"F Pacini","year":"2018","unstructured":"Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Investig 41(7):849\u2013876. https:\/\/doi.org\/10.1007\/s40618-018-0884-2","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"4_CR131","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.3390\/cancers12102894","volume":"12","author":"H Park","year":"2020","unstructured":"Park H, Park J, Choi MS, Kim J, Kim H, Shin JH et al (2020) Preoperative serum calcitonin and its correlation with extent of lymph node metastasis in medullary thyroid carcinoma. Cancers (Basel) 12(10):2894. https:\/\/doi.org\/10.3390\/cancers12102894","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4_CR132","doi-asserted-by":"publisher","first-page":"15663","DOI":"10.1038\/s41598-023-42907-3","volume":"13","author":"H Park","year":"2023","unstructured":"Park H, Ryu HJ, Heo J, Chung MK, Son YI, Kim JH et al (2023) Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy. Sci Rep 13(1):15663. https:\/\/doi.org\/10.1038\/s41598-023-42907-3","journal-title":"Sci Rep"},{"issue":"12","key":"4_CR133","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1210\/jc.2018-01386","volume":"103","author":"SY Park","year":"2018","unstructured":"Park SY, Cho YY, Kim HI, Choe JH, Kim JH, Kim JS et al (2018) Clinical validation of the prognostic stage groups of the eighth-edition TNM staging for medullary thyroid carcinoma. J Clin Endocrinol Metab 103(12):4609\u20134616. https:\/\/doi.org\/10.1210\/jc.2018-01386","journal-title":"J Clin Endocrinol Metab"},{"key":"4_CR134","doi-asserted-by":"publisher","first-page":"1101410","DOI":"10.3389\/fendo.2023.1101410","volume":"14","author":"J Patel","year":"2023","unstructured":"Patel J, Klopper J, Cottrill EE (2023) Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities. Front Endocrinol (Lausanne) 14:1101410. https:\/\/doi.org\/10.3389\/fendo.2023.1101410","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4_CR135","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.surg.2007.09.013","volume":"142","author":"FJ Quayle","year":"2007","unstructured":"Quayle FJ, Fialkowski EA, Benveniste R, Moley JF (2007) Pheochromocytoma penetrance varies by RET mutation in MEN 2A. Surgery 142(6):800\u2013805; discussion 805.e801. https:\/\/doi.org\/10.1016\/j.surg.2007.09.013","journal-title":"Surgery"},{"issue":"1","key":"4_CR136","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.surg.2016.04.053","volume":"161","author":"RW Randle","year":"2017","unstructured":"Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS, Schneider DF, Pitt SC (2017) Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161(1):137\u2013146. https:\/\/doi.org\/10.1016\/j.surg.2016.04.053","journal-title":"Surgery"},{"issue":"9","key":"4_CR137","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1089\/thy.2022.0189","volume":"32","author":"GW Randolph","year":"2022","unstructured":"Randolph GW, Sosa JA, Hao Y, Angell TE, Shonka DC Jr, Li Volsi VA et al (2022) Preoperative identification of medullary thyroid carcinoma (MTC): clinical validation of the Afirma MTC RNA-sequencing classifier. Thyroid 32(9):1069\u20131076. https:\/\/doi.org\/10.1089\/thy.2022.0189","journal-title":"Thyroid"},{"issue":"5","key":"4_CR138","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s004230050143","volume":"383","author":"F Raue","year":"1998","unstructured":"Raue F (1998) German medullary thyroid carcinoma\/multiple endocrine neoplasia registry. German MTC\/MEN study group. Medullary thyroid carcinoma\/multiple endocrine neoplasia type 2. Langenbeck\u2019s Arch Surg 383(5):334\u2013336. https:\/\/doi.org\/10.1007\/s004230050143","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"9","key":"4_CR139","doi-asserted-by":"publisher","first-page":"e3582","DOI":"10.1210\/clinem\/dgab326","volume":"106","author":"F Raue","year":"2021","unstructured":"Raue F, Bruckner T, Frank-Raue K (2021) Similar stage-dependent survival and outcome in sporadic and hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 106(9):e3582\u2013e3591. https:\/\/doi.org\/10.1210\/clinem\/dgab326","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR140","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1210\/jc.2017-01884","volume":"103","author":"F Raue","year":"2018","unstructured":"Raue F, Dralle H, Machens A, Bruckner T, Frank-Raue K (2018) Long-term survivorship in multiple endocrine neoplasia type 2B diagnosed before and in the new millennium. J Clin Endocrinol Metab 103(1):235\u2013243. https:\/\/doi.org\/10.1210\/jc.2017-01884","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4_CR141","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10689-010-9320-2","volume":"9","author":"F Raue","year":"2010","unstructured":"Raue F, Frank-Raue K (2010) Update multiple endocrine neoplasia type 2. Fam Cancer 9(3):449\u2013457. https:\/\/doi.org\/10.1007\/s10689-010-9320-2","journal-title":"Fam Cancer"},{"issue":"8","key":"4_CR142","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1210\/js.2018-00178","volume":"2","author":"F Raue","year":"2018","unstructured":"Raue F, Frank-Raue K (2018) Update on multiple endocrine neoplasia type 2: focus on medullary thyroid carcinoma. J Endocr Soc 2(8):933\u2013943. https:\/\/doi.org\/10.1210\/js.2018-00178","journal-title":"J Endocr Soc"},{"issue":"4","key":"4_CR143","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","volume":"238","author":"F Raue","year":"1995","unstructured":"Raue F, Kraimps JL, Dralle H, Cougard P, Proye C, Frilling A et al (1995) Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med 238(4):369\u2013373. https:\/\/doi.org\/10.1111\/j.1365-2796.1995.tb01212.x","journal-title":"J Intern Med"},{"issue":"3","key":"4_CR144","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1365-2265.2008.03229.x","volume":"69","author":"G Rendl","year":"2008","unstructured":"Rendl G, Manzl M, Hitzl W, Sungler P, Pirich C (2008) Long-term prognosis of medullary thyroid carcinoma. Clin Endocrinol 69(3):497\u2013505. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03229.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"4_CR145","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/thy.2008.0102","volume":"19","author":"T Rink","year":"2009","unstructured":"Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Grunwald F (2009) Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19(4):327\u2013332. https:\/\/doi.org\/10.1089\/thy.2008.0102","journal-title":"Thyroid"},{"issue":"11","key":"4_CR146","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.18632\/oncotarget.23986","volume":"9","author":"C Romei","year":"2018","unstructured":"Romei C, Ciampi R, Casella F, Tacito A, Torregrossa L, Ugolini C et al (2018) RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases. Oncotarget 9(11):9875\u20139884. https:\/\/doi.org\/10.18632\/oncotarget.23986","journal-title":"Oncotarget"},{"issue":"3","key":"4_CR147","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/ERC-17-0389","volume":"25","author":"P Romeo","year":"2018","unstructured":"Romeo P, Colombo C, Granata R, Calareso G, Gualeni AV, Dugo M et al (2018) Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients. Endocr Relat Cancer 25(3):217\u2013231. https:\/\/doi.org\/10.1530\/ERC-17-0389","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"4_CR148","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000478927","volume":"6","author":"G Russ","year":"2017","unstructured":"Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L (2017) European thyroid association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. Eur Thyroid J 6(5):225\u2013237. https:\/\/doi.org\/10.1159\/000478927","journal-title":"Eur Thyroid J"},{"issue":"19","key":"4_CR149","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.3390\/cancers15194865","volume":"15","author":"N Sahakian","year":"2023","unstructured":"Sahakian N, Castinetti F, Romanet P (2023) Molecular basis and natural history of medullary thyroid cancer: it is (almost) all in the RET. Cancers (Basel) 15(19):4865. https:\/\/doi.org\/10.3390\/cancers15194865","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4_CR150","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hed.25463","volume":"41","author":"K Saltiki","year":"2019","unstructured":"Saltiki K, Simeakis G, Anagnostou E, Zapanti E, Anastasiou E, Alevizaki M (2019) Different outcomes in sporadic versus familial medullary thyroid cancer. Head Neck 41(1):154\u2013161. https:\/\/doi.org\/10.1002\/hed.25463","journal-title":"Head Neck"},{"issue":"6","key":"4_CR151","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.surg.2007.09.016","volume":"142","author":"C Scheuba","year":"2007","unstructured":"Scheuba C, Kaserer K, Bieglmayer C, Asari R, Riss P, Drosten R, Niederle B (2007) Medullary thyroid microcarcinoma recommendations for treatment\u2014a single-center experience. Surgery 142(6):1003\u20131010.; discussion 1010 e1001-1003. https:\/\/doi.org\/10.1016\/j.surg.2007.09.016","journal-title":"Surgery"},{"issue":"4","key":"4_CR152","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/00313020701444564","volume":"39","author":"HG Schneider","year":"2007","unstructured":"Schneider HG, Lam QT (2007) Procalcitonin for the clinical laboratory: a review. Pathology 39(4):383\u2013390. https:\/\/doi.org\/10.1080\/00313020701444564","journal-title":"Pathology"},{"issue":"1","key":"4_CR153","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4158\/EP10050.OR","volume":"17","author":"A Scholten","year":"2011","unstructured":"Scholten A, Schreinemakers JM, Pieterman CR, Valk GD, Vriens MR, Borel Rinkes IH (2011) Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract 17(1):7\u201315. https:\/\/doi.org\/10.4158\/EP10050.OR","journal-title":"Endocr Pract"},{"issue":"2","key":"4_CR154","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/jcem.83.2.4529","volume":"83","author":"I Schuffenecker","year":"1998","unstructured":"Schuffenecker I, Virally-Monod M, Brohet R, Goldgar D, Conte-Devolx B, Leclerc L et al (1998) Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D\u2019etude des Tumeurs a Calcitonine. J Clin Endocrinol Metab 83(2):487\u2013491. https:\/\/doi.org\/10.1210\/jcem.83.2.4529","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4_CR155","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1210\/jc.2002-021713","volume":"88","author":"C Scollo","year":"2003","unstructured":"Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M (2003) Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88(5):2070\u20132075. https:\/\/doi.org\/10.1210\/jc.2002-021713","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4_CR156","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJMoa043999","volume":"353","author":"MA Skinner","year":"2005","unstructured":"Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA Jr (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353(11):1105\u20131113. https:\/\/doi.org\/10.1056\/NEJMoa043999","journal-title":"N Engl J Med"},{"issue":"11","key":"4_CR157","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1245\/s10434-021-09683-8","volume":"28","author":"PM Spanheimer","year":"2021","unstructured":"Spanheimer PM, Ganly I, Chou JF, Capanu M, Nigam A, Ghossein RA et al (2021) Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival. Ann Surg Oncol 28(11):6572\u20136579. https:\/\/doi.org\/10.1245\/s10434-021-09683-8","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"4_CR158","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4_CR159","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","volume":"42","author":"M Takahashi","year":"1985","unstructured":"Takahashi M, Ritz J, Cooper GM (1985) Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 42(2):581\u2013588. https:\/\/doi.org\/10.1016\/0092-8674(85)90115-1","journal-title":"Cell"},{"issue":"5","key":"4_CR160","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/SLA.0b013e3180f61adc","volume":"246","author":"YY Tee","year":"2007","unstructured":"Tee YY, Lowe AJ, Brand CA, Judson RT (2007) Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review. Ann Surg 246(5):714\u2013720. https:\/\/doi.org\/10.1097\/SLA.0b013e3180f61adc","journal-title":"Ann Surg"},{"issue":"4","key":"4_CR161","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s12105-021-01323-7","volume":"15","author":"A Thomas","year":"2021","unstructured":"Thomas A, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Vaish R (2021) Papillary and medullary thyroid carcinomas presenting as collision tumors: a case series of 21 cases at a tertiary care cancer Center. Head Neck Pathol 15(4):1137\u20131146. https:\/\/doi.org\/10.1007\/s12105-021-01323-7","journal-title":"Head Neck Pathol"},{"issue":"5","key":"4_CR162","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3747\/co.26.5539","volume":"26","author":"CM Thomas","year":"2019","unstructured":"Thomas CM, Asa SL, Ezzat S, Sawka AM, Goldstein D (2019) Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines. Curr Oncol 26(5):338\u2013344. https:\/\/doi.org\/10.3747\/co.26.5539","journal-title":"Curr Oncol"},{"issue":"7","key":"4_CR163","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1590\/S1807-59322009000700015","volume":"64","author":"SP Toledo","year":"2009","unstructured":"Toledo SP, Lourenco DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo) 64(7):699\u2013706. https:\/\/doi.org\/10.1590\/S1807-59322009000700015","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"4_CR164","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2559.1992.tb00433.x","volume":"21","author":"T Tomita","year":"1992","unstructured":"Tomita T, Millard DM (1992) C-cell hyperplasia in secondary hyperparathyroidism. Histopathology 21(5):469\u2013474. https:\/\/doi.org\/10.1111\/j.1365-2559.1992.tb00433.x","journal-title":"Histopathology"},{"issue":"4","key":"4_CR165","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00423-019-01764-3","volume":"404","author":"F Torresan","year":"2019","unstructured":"Torresan F, Mian C, Cavedon E, Iacobone M (2019) Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening. Langenbeck\u2019s Arch Surg 404(4):411\u2013419. https:\/\/doi.org\/10.1007\/s00423-019-01764-3","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"1","key":"4_CR166","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12020-021-02892-x","volume":"75","author":"P Trimboli","year":"2022","unstructured":"Trimboli P, Giannelli J, Marques B, Piccardo A, Crescenzi A, Deandrea M (2022) Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis. Endocrine 75(1):33\u201339. https:\/\/doi.org\/10.1007\/s12020-021-02892-x","journal-title":"Endocrine"},{"issue":"2","key":"4_CR167","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/cen.12563","volume":"82","author":"P Trimboli","year":"2015","unstructured":"Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega S et al (2015) Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol 82(2):280\u2013285. https:\/\/doi.org\/10.1111\/cen.12563","journal-title":"Clin Endocrinol"},{"issue":"1","key":"4_CR168","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40463-018-0303-x","volume":"47","author":"S Turkdogan","year":"2018","unstructured":"Turkdogan S, Forest VI, Hier MP, Tamilia M, Florea A, Payne RJ (2018) Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer. J Otolaryngol Head Neck Surg 47(1):55. https:\/\/doi.org\/10.1186\/s40463-018-0303-x","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"7","key":"4_CR169","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.oraloncology.2013.03.443","volume":"49","author":"RM Tuttle","year":"2013","unstructured":"Tuttle RM, Ganly I (2013) Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging. Oral Oncol 49(7):695\u2013701. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.03.443","journal-title":"Oral Oncol"},{"issue":"1","key":"4_CR170","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.1210\/jc.2010-0959","volume":"96","author":"LA Valle","year":"2011","unstructured":"Valle LA, Kloos RT (2011) The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab 96(1):E109\u2013E113. https:\/\/doi.org\/10.1210\/jc.2010-0959","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4_CR171","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1530\/EC-21-0030","volume":"10","author":"I Vardarli","year":"2021","unstructured":"Vardarli I, Weber M, Weidemann F, Fuhrer D, Herrmann K, Gorges R (2021) Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: a meta-analysis. Endocr Connect 10(3):358\u2013370. https:\/\/doi.org\/10.1530\/EC-21-0030","journal-title":"Endocr Connect"},{"issue":"6","key":"4_CR172","doi-asserted-by":"publisher","first-page":"dgaa077","DOI":"10.1210\/clinem\/dgaa077","volume":"105","author":"T Vogel","year":"2020","unstructured":"Vogel T, Wendler J, Frank-Raue K, Kreissl MC, Spitzweg C, Fassnacht M et al (2020) Bone metastases in medullary thyroid carcinoma: high morbidity and poor prognosis associated with osteolytic morphology. J Clin Endocrinol Metab 105(6):dgaa077. https:\/\/doi.org\/10.1210\/clinem\/dgaa077","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4_CR173","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cncr.24738","volume":"116","author":"MA Walter","year":"2010","unstructured":"Walter MA, Meier C, Radimerski T, Iten F, Kranzlin M, Muller-Brand J et al (2010) Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 116(1):31\u201340. https:\/\/doi.org\/10.1002\/cncr.24738","journal-title":"Cancer"},{"issue":"6","key":"4_CR174","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1007\/s00268-010-0494-4","volume":"34","author":"MK Walz","year":"2010","unstructured":"Walz MK, Groeben H, Alesina PF (2010) Single-access retroperitoneoscopic adrenalectomy (SARA) versus conventional retroperitoneoscopic adrenalectomy (CORA): a case-control study. World J Surg 34(6):1386\u20131390. https:\/\/doi.org\/10.1007\/s00268-010-0494-4","journal-title":"World J Surg"},{"key":"4_CR175","doi-asserted-by":"publisher","first-page":"153303382090583","DOI":"10.1177\/1533033820905832","volume":"19","author":"L Wang","year":"2020","unstructured":"Wang L, Kou H, Chen W, Lu M, Zhou L, Zou C (2020) The diagnostic value of ultrasound in medullary thyroid carcinoma: a comparison with computed tomography. Technol Cancer Res Treat 19:1533033820905832. https:\/\/doi.org\/10.1177\/1533033820905832","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"4_CR176","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF et al (2015) Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6):567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"issue":"8","key":"4_CR177","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1210\/jc.2013-1204","volume":"98","author":"SA Wells Jr","year":"2013","unstructured":"Wells SA Jr, Pacini F, Robinson BG, Santoro M (2013) Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab 98(8):3149\u20133164. https:\/\/doi.org\/10.1210\/jc.2013-1204","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"4_CR178","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1210\/jcem.81.10.8855832","volume":"81","author":"N Wohllk","year":"1996","unstructured":"Wohllk N, Cote GJ, Bugalho MM, Ordonez N, Evans DB, Goepfert H et al (1996) Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 81(10):3740\u20133745. https:\/\/doi.org\/10.1210\/jcem.81.10.8855832","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"4_CR179","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/hed.26550","volume":"43","author":"AD Workman","year":"2021","unstructured":"Workman AD, Soylu S, Kamani D, Nourmahnad A, Kyriazidis N, Saade R et al (2021) Limitations of preoperative cytology for medullary thyroid cancer: proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery. Head Neck 43(3):920\u2013927. https:\/\/doi.org\/10.1002\/hed.26550","journal-title":"Head Neck"},{"issue":"1","key":"4_CR180","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1200\/JCO.21.01329","volume":"40","author":"B Xu","year":"2022","unstructured":"Xu B, Fuchs TL, Ahmadi S, Alghamdi M, Alzumaili B, Bani MA et al (2022) International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma. J Clin Oncol 40(1):96\u2013104. https:\/\/doi.org\/10.1200\/JCO.21.01329","journal-title":"J Clin Oncol"},{"issue":"6","key":"4_CR181","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.surg.2011.09.043","volume":"150","author":"DT Yip","year":"2011","unstructured":"Yip DT, Hassan M, Pazaitou-Panayiotou K, Ruan DT, Gawande AA, Gaz RD et al (2011) Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma. Surgery 150(6):1168\u20131177. https:\/\/doi.org\/10.1016\/j.surg.2011.09.043","journal-title":"Surgery"},{"key":"4_CR182","doi-asserted-by":"publisher","first-page":"1025629","DOI":"10.3389\/fendo.2022.1025629","volume":"13","author":"W Yue","year":"2022","unstructured":"Yue W, Zhang Y (2022) Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma. Front Endocrinol (Lausanne) 13:1025629. https:\/\/doi.org\/10.3389\/fendo.2022.1025629","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"4_CR183","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1002\/cam4.2217","volume":"8","author":"J Zhu","year":"2019","unstructured":"Zhu J, Li X, Wei X, Yang X, Zhao J, Zhang S, Guo Z (2019) The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma. Cancer Med 8(7):3389\u20133400. https:\/\/doi.org\/10.1002\/cam4.2217","journal-title":"Cancer Med"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-80396-3_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:59:58Z","timestamp":1742356798000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-80396-3_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031803956","9783031803963"],"references-count":183,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-80396-3_4","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"20 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}